Natural history studies and prevention trials for T1D use 2 hour OGTTs for two main goals: prediction and diagnostic surveillance. Although 2 hour OGTTs are reliable for these purposes, they impose time burdens and costs for research participants and staff. We thus examined whether 1 hour OGTTs are suitable for prediction and diagnostic surveillance. To assess their accuracy for prediction, we developed a 1 hour risk score similar to the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS). The DPTRS utilizes log fasting C-peptide, sums of 30, 60, 90 and 120-min glucose and C-peptide, age, and log BMI. The components are the same for the 1 hour risk score (DPTRS60) and the DPTRS except that 1 hour glucose and C-peptide replace the glucose sum and C-peptide sum. Diabetes Prevention Trial-Type 1 participants were included in the analysis (n=670; age at baseline: 13.8±9.6 years; 56% male; 241 diagnosed with T1D). 1 hour glucose and C-peptide were highly predictive of T1D within the DPTRS60 model, as were log fasting C-peptide, age and log BMI (all p<0.001). The receiver operating characteristic AUC was almost identical for the DPTRS and DPTRS60 (both 0.81, p<0.001). To assess diagnostic surveillance, we sought to identify a 1 hour glucose threshold below which a diagnosis of T1D would be unlikely. Of 162 (among the 241 total) diagnosed by 2 hour OGTTs, only 2 (1.2%) had a 1 hour- glucose <180 mg/dl at diagnosis. Of 172 with a 1 hour glucose <180 mg/dl at baseline who were ultimately diagnosed, only 1 (0.6%) was diagnosed before the 6±3 month window for the next monitoring visit. 568/670 (85%) had a 1 hour glucose <180 mg/dl at baseline. These findings show that 1 hour OGTTs are virtually as predictive of T1D as 2 hour OGTTs. Also, it appears that a 1 hour glucose <180 mg/dl ensures a very low risk for T1D before the next routine monitoring visit. Moreover, most 1 hour glucose values are <180 mg/dl. Accordingly, 1 hour OGTTs can reduce time burdens and costs for the majority of T1D natural history and prevention trial participants.


K. Simmons: None. J. Sosenko: None. H.M. Ismail: None. H. Elding Larsson: None. A. Steck: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at